Compare WTRG & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTRG | FMS |
|---|---|---|
| Founded | 1901 | 1996 |
| Country | United States | Germany |
| Employees | 1615 | N/A |
| Industry | Water Supply | Misc Health and Biotechnology Services |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 13.6B |
| IPO Year | 1994 | 2005 |
| Metric | WTRG | FMS |
|---|---|---|
| Price | $39.08 | $22.11 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $43.50 | $30.00 |
| AVG Volume (30 Days) | ★ 2.2M | 627.6K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.47% | 2.57% |
| EPS Growth | ★ 1.38 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $2,474,615,000.00 | N/A |
| Revenue This Year | $5.07 | N/A |
| Revenue Next Year | $7.31 | $3.83 |
| P/E Ratio | $33.59 | ★ $15.62 |
| Revenue Growth | ★ 18.62 | N/A |
| 52 Week Low | $36.11 | $20.02 |
| 52 Week High | $42.51 | $27.64 |
| Indicator | WTRG | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 33.74 | 40.19 |
| Support Level | $38.90 | $21.83 |
| Resistance Level | $39.10 | $23.99 |
| Average True Range (ATR) | 0.70 | 0.30 |
| MACD | -0.33 | 0.05 |
| Stochastic Oscillator | 14.43 | 11.71 |
Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.